Linda Schultz serves as the Head of Life Sciences for Middle Market at Zurich North America, where she leverages her extensive expertise in strategic leadership and underwriting to drive growth and innovation within the life sciences sector. With a strong focus on professional and general...
Linda Schultz serves as the Head of Life Sciences for Middle Market at Zurich North America, where she leverages her extensive expertise in strategic leadership and underwriting to drive growth and innovation within the life sciences sector. With a strong focus on professional and general liability, Linda is dedicated to enhancing Zurich's underwriting capabilities, ensuring that the company remains a trusted partner for clients navigating the complexities of the life sciences landscape.
In her current role, Linda is spearheading key projects aimed at developing comprehensive training programs and robust systems that empower her team and enhance overall operational efficiency. Her commitment to mentoring and coaching not only fosters a culture of continuous learning but also strengthens the underwriting acumen of her colleagues, enabling them to better assess risks and tailor solutions for clients.
Linda's strategic vision is complemented by her proficiency in financial analysis and account management, which she utilizes to identify emerging trends and opportunities within the life sciences market. Under her leadership, the Life Sciences Industry Practice is poised for significant growth, as she collaborates closely with industry practice leaders like John Mizzi and Alex Wells to align Zurich's offerings with the evolving needs of clients.
As she looks to the future, Linda is excited about the potential to innovate within the life sciences sector, ensuring that Zurich North America remains at the forefront of providing exceptional insurance solutions, including liability, workers compensation, umbrella insurance, and excess coverage. Her passion for the industry and dedication to excellence position her as a key player in shaping the future of life sciences underwriting at Zurich.
